- Home
- FBYD vs OLMA Comparison
FBYD vs OLMA Comparison
Compare FBYD & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBYD
- OLMA
- Stock Information
- Founded
- FBYD 2021
- OLMA 2006
- Country
- FBYD United States
- OLMA United States
- Employees
- FBYD N/A
- OLMA N/A
- Industry
- FBYD
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- FBYD
- OLMA Health Care
- Exchange
- FBYD Nasdaq
- OLMA Nasdaq
- Market Cap
- FBYD 300.5M
- OLMA 289.0M
- IPO Year
- FBYD N/A
- OLMA 2020
- Fundamental
- Price
- FBYD $8.00
- OLMA $4.96
- Analyst Decision
- FBYD
- OLMA Strong Buy
- Analyst Count
- FBYD 0
- OLMA 3
- Target Price
- FBYD N/A
- OLMA $27.67
- AVG Volume (30 Days)
- FBYD 11.2K
- OLMA 1.0M
- Earning Date
- FBYD 04-03-2025
- OLMA 05-07-2025
- Dividend Yield
- FBYD N/A
- OLMA N/A
- EPS Growth
- FBYD N/A
- OLMA N/A
- EPS
- FBYD 1.41
- OLMA N/A
- Revenue
- FBYD $6,745,000.00
- OLMA N/A
- Revenue This Year
- FBYD N/A
- OLMA N/A
- Revenue Next Year
- FBYD N/A
- OLMA N/A
- P/E Ratio
- FBYD $5.36
- OLMA N/A
- Revenue Growth
- FBYD N/A
- OLMA N/A
- 52 Week Low
- FBYD $3.62
- OLMA $2.86
- 52 Week High
- FBYD $13.25
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- FBYD 48.44
- OLMA 69.32
- Support Level
- FBYD $7.57
- OLMA $2.96
- Resistance Level
- FBYD $8.44
- OLMA $3.41
- Average True Range (ATR)
- FBYD 0.46
- OLMA 0.35
- MACD
- FBYD -0.07
- OLMA 0.21
- Stochastic Oscillator
- FBYD 46.43
- OLMA 97.67
About FBYD Falcon's Beyond Global Inc.
Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has five operating segments, Falcon's Creative Group, PDP, Sierra Parima, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.